TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

TASLY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

TASLY

ST13

US500000078277157

Classe

5

Pedido

78277157

Registro

3128633

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

54

Atualização mais recente

23/05/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5

Data de depósito

22/07/2003

Data de registro

15/08/2006

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

05/04/2016

Última transação

23/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Código do desenho

3

Tipo de titular

03

Localização do titular

TIANJIN, P.R., CN

Examinador

MAHONEY, PAULA M

Unidade examinadora

M80

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

TASLY PHARMACEUTICAL GROUP CO., LTD.
TIANJIN TASLY PHARMACEUTICAL CO., LTD.

Representantes

Kai Zhu Zhu & Co, P.C.

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Medicines for human purposes for the treatment of [insomnia, pulmonary disease, nephropathy, hepatopathy,] heart disease, [gastric diseases, gynecopathy, dermatosis, rheumatic disease, trachoma, conjunctivitis, pneumonia, asthma, esophagus diseases, enteritis, anemia, hepatitis,] cardiovascular and cerebrovascular disease, [rheumatic arthritis, neural asthma, apoplexy, high fever, cancer, influenza, cough, febris, rubella, infantile paralysis, dysentery, impaludism, tonsillitis, laryngitis, pharyngitis, headache, sprain, trauma, bruise, eczema and duodenum ulcer;] Medicinal herbs, namely, Chinese medicines, namely, herb supplements in the forms of [decoction,] pills, drops[, powder, ointment, pellets and capsule] for the treatment of [gynecopathy, insomnia, hepatopathy,] heart disease, [gastric diseases, dermatosis, rheumatic disease,] cardiovascular and cerebrovascular disease[, rheumatic arthritis, apoplexy, high fever, influenza, cough, febris, laryngitis, pharyngitis, headache, sprain, trauma, bruise, eczema and duodenum ulcer; Biological preparations for medical purposes for thrombus dissolution, biological preparations for medical purposes for empyrosis treatment, biological preparations for medical purposes used as adjuvant of vaccine; Dietetic foods adapted for medical purposes, namely, additives to food for improvement of immunity, prevention and treatment of hyperglycemia, reduction of blood pressure, supplement of human microelement; Royal jelly for medical purposes; Depuratives, namely, ALL PURPOSE chemical disinfectant; Surgical tissues, namely, surgical gauze fabric, surgical bandages; Dental abrasives]

Publicações

Histórico de despachos e eventos da marca no USPTO.

54 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

22/05/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

22/05/2026

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

22/05/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

22/05/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

22/05/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

22/05/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

22/05/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

15/08/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

16/05/2016

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/04/2016

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

05/04/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/04/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/04/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

28/01/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

15/08/2015

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

09/02/2013

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

09/02/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/02/2013

ES8R

TEAS SECTION 8 RECEIVED

29/01/2013

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/12/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

15/08/2006

ATRV

ATTORNEY REVIEW COMPLETED

27/06/2006

ATRQ

ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED

23/06/2006

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

19/06/2006

PUBO

PUBLISHED FOR OPPOSITION

23/05/2006

NPUB

NOTICE OF PUBLICATION

03/05/2006

AMPB

AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED

11/04/2006

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

17/02/2006

PETR

PETITION TO REVIVE-RECEIVED

09/01/2006

MAIL

PAPER RECEIVED

09/01/2006

EEXT

SOU TEAS EXTENSION RECEIVED

05/01/2006

ATRQ

ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED

30/09/2005

PCGR

PETITION TO DIRECTOR GRANTED

30/09/2005

PCRC

PETITION TO DIRECTOR RECEIVED

05/07/2005

MAIL

PAPER RECEIVED

05/07/2005

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

05/07/2005

PUBO

PUBLISHED FOR OPPOSITION

12/04/2005

NPUB

NOTICE OF PUBLICATION

23/03/2005

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/01/2005

ACEC

AMENDMENT FROM APPLICANT ENTERED

07/01/2005

ALIE

ASSIGNED TO LIE

05/01/2005

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

18/12/2004

ACEC

AMENDMENT FROM APPLICANT ENTERED

16/12/2004

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/12/2004

MAIL

PAPER RECEIVED

03/12/2004

GNFR

FINAL REFUSAL E-MAILED

30/09/2004

CNFR

FINAL REFUSAL WRITTEN

30/09/2004

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

29/09/2004

MAIL

PAPER RECEIVED

29/09/2004

ACEC

AMENDMENT FROM APPLICANT ENTERED

09/09/2004

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/08/2004

MAIL

PAPER RECEIVED

20/08/2004

GNRT

NON-FINAL ACTION E-MAILED

25/02/2004

DOCK

ASSIGNED TO EXAMINER

06/02/2004

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace TASLY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.